Table 1.

Competitive reconstitution of irradiated mice with various fetal liver HSC populations reveals that CD48 enhances the purity of fetal liver HSCs


Donor cells

Cell dose

Mice with engrafted cells

Frequency of engrafted cells

Mice with long-term multilineage reconstitution

Frequency of mice that were long-term multilineage reconstituted (%)
TSLM   3   4 of 10   1 in 6.4   3 of 10   1 in 8.9 (11)  
CD48- SLM   10   3 of 4   1 in 7.7   3 of 4   1 in 7.7 (13)  
CD48+ SLM   10   0 of 8   NA   NA   NA  
CD48- TSLM   3   15 of 21   1 in 2.9   10 of 21   1 in 5.2 (19)  
CD48- TSLM
 
1
 
9 of 14
 
1 in 1.6
 
5 of 14
 
1 in 2.8 (36)
 

Donor cells

Cell dose

Mice with engrafted cells

Frequency of engrafted cells

Mice with long-term multilineage reconstitution

Frequency of mice that were long-term multilineage reconstituted (%)
TSLM   3   4 of 10   1 in 6.4   3 of 10   1 in 8.9 (11)  
CD48- SLM   10   3 of 4   1 in 7.7   3 of 4   1 in 7.7 (13)  
CD48+ SLM   10   0 of 8   NA   NA   NA  
CD48- TSLM   3   15 of 21   1 in 2.9   10 of 21   1 in 5.2 (19)  
CD48- TSLM
 
1
 
9 of 14
 
1 in 1.6
 
5 of 14
 
1 in 2.8 (36)
 

The indicated number of donor-type (CD45.2+) cells from fetal liver were transplanted intravenously into lethally irradiated adult recipients (CD45.1+) along with 200 000 recipient-type whole bone marrow cells for radioprotection. Recipients were considered engrafted by donor cells if any CD45.2+ cells were detected in their peripheral blood (above background: > 0.3% of white blood cells). Mice were considered long-term multilineage reconstituted if donor-type myeloid, B, and T cells were present for more than 16 weeks after reconstitution. The frequency of HSCs was calculated by Poisson limit-dilution statistics6,26  based on the frequency of mice that became long-term multilineage reconstituted.

TSLM indicates ThylowSca-1+lineage-Mac-1+ fetal liver cells; NA, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal